Wischhusen, Jörg

Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

Wischhusen, J., Melero, I., & Fridman, W. H. (2020) · Frontiers in Immunology

GDF15 and Related BiomarkersTGF-β signaling in diseases

Cited by 506

CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death

Wischhusen, J., Naumann, U., Ohgaki, H., Rastinejad, F., & Weller, M. (2003) · Oncogene

Cancer-related Molecular PathwaysCell death mechanisms and regulation

Cited by 158

Neurodegeneration by α-synuclein-specific T cells in AAV-A53T-α-synuclein Parkinson’s disease mice

Karikari, A. A., McFleder, R. L., Ribechini, E., Blum, R., Bruttel, V., Knorr, S., Gehmeyr, M., Volkmann, J., Brotchie, J. M., Ahsan, F., et al. (2022) · Brain, Behavior, and Immunity

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 116

Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene

Gupta, R., Dittmeier, M., Wohlleben, G., Nickl, V., Bischler, T., Luzak, V., Wegat, V., Doll, D., Sodmann, A., Bady, E., et al. (2024) · Cancer Gene Therapy

Glioma Diagnosis and TreatmentCancer Mechanisms and Therapy

Cited by 7